RE-HEAL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
RE-HEAL
Largest movements
- Cash +€19,625
up €19,625 (+112%), from €17,552 to €37,177
mainly Net result for the year (+€18,553) and Receivables within one year (+€976)
- Receivables within one year -€976
down €976 (-6.1%), from €16,113 to €15,138
of which Trade receivables: -€6,050
- Reserves +€18,553
up €18,553 (+206%), from €8,988 to €27,541
- Taxes +€2,800
up €2,800 (+41.9%), from €6,684 to €9,484
- Gross operating margin -€2,562
down €2,562 (-8.3%), from €30,876 to €28,314
- Depreciation -€1,032
no longer reported in 2026 (was €1,032)
From the 2025 result to the 2026 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2025 and 2026 balance sheets and the 2026 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2025 | 2026 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €33,665 | €52,565 | +€18,900 | +56.1% |
| Current assets | 29/58 | €33,665 | €52,565 | +€18,900 | +56.1% |
| Amounts receivable within one year | 40/41 | €16,113 | €15,138 | -€976 | -6.1% |
| Trade receivables | 40 | €11,102 | €5,052 | -€6,050 | -54.5% |
| Other amounts receivable | 41 | €5,012 | €10,086 | +€5,074 | +101% |
| Cash at bank and in hand | 54/58 | €17,552 | €37,177 | +€19,625 | +112% |
| Deferred charges and accrued income | 490/1 | - | €250 | +€250 | |
| Total equity and liabilities | 10/49 | €33,665 | €52,565 | +€18,900 | +56.1% |
| Equity | 10/15 | €27,588 | €46,141 | +€18,553 | +67.2% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €8,988 | €27,541 | +€18,553 | +206% |
| Distributable reserves | 133 | €8,988 | €27,541 | +€18,553 | +206% |
| Amounts payable | 17/49 | €6,077 | €6,425 | +€347 | +5.7% |
| Amounts payable within one year | 42/48 | €6,077 | €6,425 | +€347 | +5.7% |
| Trade debts | 44 | €1,155 | €1,501 | +€347 | +30.0% |
| Suppliers | 440/4 | €1,155 | €1,501 | +€347 | +30.0% |
| Taxes, remuneration and social security | 45 | €4,923 | €4,924 | +€1 | 0.0% |
| Taxes | 450/3 | €4,923 | €4,924 | +€1 | 0.0% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,032 | - | -€1,032 | |
| Other operating charges | 640/8 | €449 | €462 | +€12 | +2.8% |
| Gross operating margin | 9900 | €30,876 | €28,314 | -€2,562 | -8.3% |
| Operating profit (loss) | 9901 | €29,394 | €27,852 | -€1,542 | -5.2% |
| Financial income | 75/76B | - | €250 | +€250 | |
| Recurring financial income | 75 | - | €250 | +€250 | |
| Financial charges | 65/66B | €65 | €67 | +€1 | +2.0% |
| Recurring financial charges | 65 | €65 | €67 | +€1 | +2.0% |
| Profit (loss) for the period before taxes | 9903 | €29,329 | €28,036 | -€1,293 | -4.4% |
| Income taxes | 67/77 | €6,684 | €9,484 | +€2,800 | +41.9% |
| Profit (loss) for the period | 9904 | €22,645 | €18,553 | -€4,093 | -18.1% |
| Profit (loss) for the period to be appropriated | 9905 | €22,645 | €18,553 | -€4,093 | -18.1% |
Source: filed annual accounts (NBB), financial years ended 31 March 2025 and 31 March 2026. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 20 October 2026 via checked.be.